Changes in the use of diabetes drugs among community-dwelling people with Alzheimer’s disease

BACKGROUND: Type 2 diabetes is common in persons with Alzheimer’s disease (AD). Management of diabetes in persons with AD is challenging due to changing goals of care and susceptibility to adverse drug events including hypoglycemia. The aim of this study was to investigate the prevalence of diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Rubio, Carlos, Koponen, Marjaana, Lampela, Pasi, Taipale, Heidi, Tanskanen, Antti, Bell, J. Simon, Tolppanen, Anna-Maija, Hartikainen, Sirpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672592/
https://www.ncbi.nlm.nih.gov/pubmed/34911481
http://dx.doi.org/10.1186/s12877-021-02694-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672592/
https://www.ncbi.nlm.nih.gov/pubmed/34911481
http://dx.doi.org/10.1186/s12877-021-02694-w

Ejemplares similares